According to Mankind Pharma's latest financial reports the company has $0.29 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-03-31 | $0.40 B | 119.33% |
2023-03-31 | $0.18 B | 9.9% |
2022-03-31 | $0.16 B | -38.45% |
2021-03-31 | $0.27 B | 90.21% |
2020-03-31 | $0.14 B |